Skip to main content

ORIGINAL RESEARCH article

Front. Nutr.
Sec. Clinical Nutrition
Volume 11 - 2024 | doi: 10.3389/fnut.2024.1435297

Dietary niacin intake and mortality among chronic kidney disease patients

Provisionally accepted
Zhengxi Zhou Zhengxi Zhou 1Xiaotian Yao Xiaotian Yao 2,3*
  • 1 Department of Urology, Ningbo Mingzhou Hospital, Zhejiang, China., Zhejiang, China
  • 2 Department of Nephrology, Sixth Affiliated Hospital of Sun Yat-sen University, Guang Zhou, China
  • 3 Biomedical Innovation Center, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

The final, formatted version of the article will be published soon.

    The relationship between niacin and the risk of mortality in chronic kidney disease (CKD) patients remains unclear. This study aims to investigate the potential correlation. Methods This cohort study utilized data from the 2003-2018 National Health and Nutrition Examination Survey (NHANES). The study included 6,110 patients with CKD aged 18 years or older. Weighted Cox proportional hazards models and restricted cubic splines (RCS) were employed to estimate hazard ratios for all-cause mortality and cardiovascular disease (CVD) mortality. Niacin intake was estimated using the 24-hour dietary recall method, based on the type and amount of food consumed. All-cause mortality and cardiac mortality rates were determined using National Death Index (NDI) mortality data (as of 31 December 2018).The median niacin intake was 20.89 mg/day, with an interquartile range of 15.67-27.99 mg/day. During the follow-up period (median of 87 months), there were 1,984 all-cause deaths, including 714 CVD deaths. Compared with low niacin intake, the multivariate-adjusted hazard ratio for dietary intake of 22 mg or higher was 0.71 (95% CI, 0.57-0.88) for all-cause mortality and 0.75 (95% CI, 0.57,0.98) for CVD mortality.Dietary niacin intake is associated with a reduction in all-cause and cardiac mortality among CKD patients.

    Keywords: Niacin, CKD, NHANES, All-cause mortality, Cardiac mortality

    Received: 20 May 2024; Accepted: 04 Nov 2024.

    Copyright: © 2024 Zhou and Yao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Xiaotian Yao, Department of Nephrology, Sixth Affiliated Hospital of Sun Yat-sen University, Guang Zhou, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.